Fernando Escalante-Barrigón

7PUBLICATIONS
84CO-AUTHORS
AutoimmunityInnate immunityMedical mycologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 19, 2026
Quantitative MYD88 L265P and flow cytometry levels for outcome determination in IgM gammopathies: the SAL-TO study.

Irene Dogliotti, Cristina Jiménez, Veronica Peri

|Jan 29, 2026
Immune biomarkers of increased infection risk in multiple myeloma.

Aintzane Zabaleta, Luis-Esteban Tamariz-Amador, Ioannis V Kostopoulos

|Aug 19, 2025
Prospective real-world evaluation of t(11;14) prevalence and disease biology in multiple myeloma: MEDICI study analysis.

Andrew Spencer, Maria Gavriatopoulou, Daniel Coriu

|Jul 22, 2024
Curative Strategy for High-Risk Smoldering Myeloma: Carfilzomib, Lenalidomide, and Dexamethasone (KRd) Followed by Transplant, KRd Consolidation, and Rd Maintenance.

María-Victoria Mateos, Joaquin Martínez-López, Paula Rodriguez Otero

|Jul 26, 2023
Clonal architecture and evolutionary history of Waldenström's macroglobulinemia at the single-cell level.

Ramón García-Sanz, María García-Álvarez, Alejandro Medina

Pageof 2